PRF Technologies Ltd. Ordinary Shares (PRFX) is a publicly traded Healthcare sector company. As of May 21, 2026, PRFX trades at $1.62 with a market cap of $1.29M and a P/E ratio of 0.00. PRFX moved +0.00% today. Year to date, PRFX is -52.47%; over the trailing twelve months it is -83.49%. Its 52-week range spans $1.41 to $83.15. Rallies surfaces PRFX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PRF Technologies Advances OcuRing-K to Phase I Support, Secures 71MW Solar SaaS Deal: PRF completed acquisition of DeepSolar and majority investment in LayerBio, advancing OcuRing™-K through IND-supporting activities with Phase I safety data and confirming multi-drug ocular delivery potential. DeepSolar launched Smart TDD, joined NVIDIA Connect, secured a 71MW Romanian SaaS contract and filed its first patent, ending 2025 with $4.1M cash.
| Metric | Value |
|---|---|
| Price | $1.62 |
| Market Cap | $1.29M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $83.15 |
| 52-Week Low | $1.41 |
| Volume | 310.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PRFX analyst coverage data. Average price target: $0.00.